FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| QuVa Pharma, Inc. | 079937015 | 70092-100 | 70092-100-50 | Fentanyl Citrate | 2750 ug/55 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Fentanyl Citrate | 60000 ug/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | Fentanyl Citrate | 30000 ug/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Fentanyl Citrate | 2500 ug/250 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Fentanyl Citrate | 1000 ug/100 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-094 | 70092-094-36 | Fentanyl Citrate | 2 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-250 | 70092-250-75 | Fentanyl Citrate | 1 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-097 | 70092-097-43 | Fentanyl Citrate | 100 ug/2 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-098 | 70092-098-44 | Fentanyl Citrate | 250 ug/5 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-509 | 70092-509-35 | Fentanyl Citrate | 2500 ug/50 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-444 | 70092-444-05 | Fentanyl Citrate | 1250 ug/250 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-099 | 70092-099-49 | Fentanyl Citrate | 1500 ug/30 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-104 | 70092-104-36 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 125 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-105 | 70092-105-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 500 ug/250 mL; 312.5 mg/250 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-255 | 70092-255-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 100 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-202 | 70092-202-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 125 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-160 | 70092-160-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 500 ug/250 mL; 250 mg/250 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Fentanyl Citrate; Bupivacaine Hydrochloride | 6000 ug/3000 mL; 3000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | Fentanyl Citrate; Bupivacaine Hydrochloride | 6000 ug/3000 mL; 3750 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 200 ug/100 mL; 100 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Fentanyl Citrate; Ropivacaine Hydrochloride | 6000 ug/3000 mL; 3000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | Fentanyl Citrate; Ropivacaine Hydrochloride | 6000 ug/3000 mL; 6000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-207 | 70092-207-37 | Fentanyl Citrate; Ropivacaine Hydrochloride | 400 ug/200 mL; 200 mg/200 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-441 | 70092-441-76 | Fentanyl Citrate; Ropivacaine Hydrochloride | 400 ug/200 mL; 200 mg/200 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-108 | 70092-108-36 | Fentanyl Citrate; Ropivacaine Hydrochloride | 200 ug/100 mL; 200 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Heparin Sodium | 3000 U/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-216 | 70092-216-50 | Heparin Sodium | 50 U/50 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-217 | 70092-217-47 | Heparin Sodium | 20 U/20 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-281 | 70092-281-08 | Heparin Sodium | 30000 U/1000 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-111 | 70092-111-48 | Hydromorphone Hydrochloride | 6 mg/30 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-118 | 70092-118-50 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 036662848 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-290 | 70092-290-49 | Hydromorphone Hydrochloride | 15 mg/30 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 036662848 | Hydromorphone Hydrochloride | 10 mg/50 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Hydromorphone Hydrochloride | 6 mg/30 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-293 | 70092-293-49 | Hydromorphone Hydrochloride | 30 mg/30 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 036662848 | Hydromorphone Hydrochloride | 600 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-115 | 70092-115-36 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-287 | 70092-287-35 | Hydromorphone Hydrochloride | 10 mg/50 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-114 | 70092-114-50 | Hydromorphone Hydrochloride | 10 mg/50 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-116 | 70092-116-75 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-286 | 70092-286-74 | Hydromorphone Hydrochloride | 10 mg/50 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 036662848 | Hydromorphone Hydrochloride | 3000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | Hydromorphone Hydrochloride | 1500 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-546 | 70092-546-35 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-294 | 70092-294-74 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Hydromorphone Hydrochloride | 600 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | Hydromorphone Hydrochloride | 3000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Ketamine | 30000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-119 | 70092-119-44 | Ketamine Hydrochloride | 50 mg/5 mL | 2025-2 | valid | 2026-08-12 |